(UroToday.com) The European Society of Medical Oncology (ESMO) 2021 virtual annual meeting’s prostate cancer session included a presentation by Dr. Nobuaki Matsubara estimating overall survival with subsequent treatment effect by applying inverse probability of censoring weighting in the LATITUDE study.1